Dillon Adrian T. - 01 Feb 2022 Form 4/A - Amendment Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Director
Signature
/s/ Delano W. Ladd, attorney-in-fact
Issuer symbol
HQY
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
29 Apr 2022, 17:54:17 UTC
Date Of Original Report
03 Feb 2022
Previous filing
15 Dec 2021
Next filing
27 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Award $0 +1,455 +3.3% $0.000000 45,538 01 Feb 2022 Direct F1, F2
transaction HQY Common Stock Award $0 +1,819 +4% $0.000000 47,357 01 Feb 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HQY Stock Option (right to buy) 4,837 01 Feb 2022 Common Stock 4,837 $46.40 Direct F4
holding HQY Stock Option (right to buy) 4,339 01 Feb 2022 Common Stock 4,339 $50.41 Direct F4
holding HQY Stock Option (right to buy) 3,626 01 Feb 2022 Common Stock 3,626 $63.64 Direct F4
holding HQY Stock Option (right to buy) 7,632 01 Feb 2022 Common Stock 7,632 $32.50 Direct F4
holding HQY Stock Option (right to buy) 4,012 01 Feb 2022 Common Stock 4,012 $66.06 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct an error in the number of shares of Common Stock reported as acquired in the original Form 4.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's annual stockholder meeting held in the current fiscal year. Vested shares will be delivered to the reporting person upon vesting.
F3 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 455 shares on February 1, 2022. An additional 455 shares will vest on each of May 1 and August 1, of 2022. The remaining 454 shares will vest on November 1, 2022. Vested shares will be delivered to the reporting person upon vesting.
F4 The option is immediately exercisable.

Remarks:

The Power of Attorney given by Mr. Dillon was previously filed with the U.S. Securities & Exchange Commission on September 6, 2016 as an exhibit to a statement on Form 3 filed by Mr. Dillon with respect to HealthEquity, Inc. and is hereby incorporated by reference.